Quantitative Evaluation of Hormesis in Breast Cancer Using Histoculture Drug Response Assay.

Conclusion: We evaluated hormesis in breast cancer tissue using HDRA for the first time although previously confirmed in cultured cells. Hormesis seems to occur in patients undergoing treatment with anticancer agents, especially in a metastatic setting. Meanwhile, tumor growth may be stimulated in patients who are resistant to paclitaxel.
PMID: 31903070 [PubMed]

Source: Dose Response - September 30, 2019 Category: Drugs & Pharmacology Authors: Aoishi Y, Yoshimasu T, Oura S, Kawago M, Hirai Y, Miyasaka M, Ohashi T, Nishimura Y Tags: Dose Response Source Type: research